DENTSPLY SIRONA Inc. (XRAY)
USD 18.68
(-2.66%)
USD 18.68
(-2.66%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.79 Billion USD | 1.76% |
| 2022 | 1.76 Billion USD | 2.38% |
| 2021 | 1.72 Billion USD | 20.0% |
| 2020 | 1.43 Billion USD | -16.74% |
| 2019 | 1.72 Billion USD | 0.26% |
| 2018 | 1.71 Billion USD | 2.65% |
| 2017 | 1.67 Billion USD | 9.96% |
| 2016 | 1.52 Billion USD | 41.37% |
| 2015 | 1.07 Billion USD | -5.76% |
| 2014 | 1.14 Billion USD | -0.16% |
| 2013 | 1.14 Billion USD | -0.33% |
| 2012 | 1.14 Billion USD | 22.62% |
| 2011 | 936.84 Million USD | 26.79% |
| 2010 | 738.9 Million USD | 2.17% |
| 2009 | 723.22 Million USD | -2.16% |
| 2008 | 739.16 Million USD | 8.62% |
| 2007 | 680.53 Million USD | 12.86% |
| 2006 | 602.98 Million USD | 7.04% |
| 2005 | 563.34 Million USD | 3.51% |
| 2004 | 544.26 Million USD | 8.52% |
| 2003 | 501.51 Million USD | 4.67% |
| 2002 | 479.13 Million USD | 22.44% |
| 2001 | 391.3 Million USD | 14.72% |
| 2000 | 341.09 Million USD | 5.93% |
| 1999 | 322 Million USD | 3.01% |
| 1998 | 312.6 Million USD | 16.34% |
| 1997 | 268.7 Million USD | 15.17% |
| 1996 | 233.3 Million USD | 15.72% |
| 1995 | 201.6 Million USD | 11.81% |
| 1994 | 180.3 Million USD | -9.76% |
| 1993 | 199.8 Million USD | 914.21% |
| 1992 | 19.7 Million USD | 52.71% |
| 1991 | 12.9 Million USD | 92.54% |
| 1990 | 6.7 Million USD | 52.27% |
| 1989 | 4.4 Million USD | 12.82% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 439 Million USD | -4.36% |
| 2024 Q1 | 459 Million USD | 0.0% |
| 2023 Q4 | 459 Million USD | 9.81% |
| 2023 Q1 | 462 Million USD | 3.82% |
| 2023 FY | 1.79 Billion USD | 1.76% |
| 2023 Q3 | 418 Million USD | -10.11% |
| 2023 Q2 | 465 Million USD | 0.65% |
| 2022 Q4 | 445 Million USD | 0.68% |
| 2022 Q3 | 442 Million USD | -2.86% |
| 2022 Q2 | 455 Million USD | 8.59% |
| 2022 Q1 | 419 Million USD | -3.23% |
| 2022 FY | 1.76 Billion USD | 2.38% |
| 2021 Q2 | 438 Million USD | 3.79% |
| 2021 FY | 1.72 Billion USD | 20.0% |
| 2021 Q4 | 433 Million USD | 0.93% |
| 2021 Q1 | 422 Million USD | 0.24% |
| 2021 Q3 | 429 Million USD | -2.05% |
| 2020 Q3 | 341.9 Million USD | 22.5% |
| 2020 FY | 1.43 Billion USD | -16.74% |
| 2020 Q1 | 393.5 Million USD | -14.72% |
| 2020 Q4 | 421 Million USD | 23.14% |
| 2020 Q2 | 279.1 Million USD | -29.07% |
| 2019 FY | 1.72 Billion USD | 0.26% |
| 2019 Q2 | 430.9 Million USD | -0.23% |
| 2019 Q4 | 461.4 Million USD | 15.55% |
| 2019 Q3 | 399.3 Million USD | -7.33% |
| 2019 Q1 | 431.9 Million USD | -0.3% |
| 2018 Q1 | 435.2 Million USD | 3.15% |
| 2018 Q4 | 433.2 Million USD | 3.51% |
| 2018 Q3 | 418.5 Million USD | -3.17% |
| 2018 FY | 1.71 Billion USD | 2.65% |
| 2018 Q2 | 432.2 Million USD | -0.69% |
| 2017 Q4 | 421.9 Million USD | -2.0% |
| 2017 FY | 1.67 Billion USD | 9.96% |
| 2017 Q3 | 430.5 Million USD | 3.09% |
| 2017 Q2 | 417.6 Million USD | 3.19% |
| 2017 Q1 | 404.7 Million USD | 1.25% |
| 2016 FY | 1.52 Billion USD | 41.37% |
| 2016 Q1 | 342.1 Million USD | 27.74% |
| 2016 Q4 | 399.7 Million USD | 5.43% |
| 2016 Q3 | 379.1 Million USD | -5.72% |
| 2016 Q2 | 402.1 Million USD | 17.54% |
| 2015 FY | 1.07 Billion USD | -5.76% |
| 2015 Q3 | 264.3 Million USD | -3.88% |
| 2015 Q4 | 267.8 Million USD | 1.32% |
| 2015 Q2 | 274.97 Million USD | 1.76% |
| 2015 Q1 | 270.23 Million USD | -4.57% |
| 2014 Q3 | 275.98 Million USD | -6.8% |
| 2014 Q1 | 287.84 Million USD | -1.47% |
| 2014 FY | 1.14 Billion USD | -0.16% |
| 2014 Q4 | 283.16 Million USD | 2.6% |
| 2014 Q2 | 296.12 Million USD | 2.88% |
| 2013 Q1 | 293.67 Million USD | 1.97% |
| 2013 Q2 | 289.92 Million USD | -1.28% |
| 2013 Q3 | 269.16 Million USD | -7.16% |
| 2013 Q4 | 292.12 Million USD | 8.53% |
| 2013 FY | 1.14 Billion USD | -0.33% |
| 2012 Q1 | 304.35 Million USD | 3.66% |
| 2012 Q2 | 296.03 Million USD | -2.73% |
| 2012 Q3 | 260.35 Million USD | -12.05% |
| 2012 Q4 | 287.99 Million USD | 10.62% |
| 2012 FY | 1.14 Billion USD | 22.62% |
| 2011 Q1 | 200.76 Million USD | 7.69% |
| 2011 FY | 936.84 Million USD | 26.79% |
| 2011 Q4 | 293.6 Million USD | 26.83% |
| 2011 Q3 | 231.49 Million USD | 9.72% |
| 2011 Q2 | 210.98 Million USD | 5.09% |
| 2010 Q2 | 182.38 Million USD | -3.01% |
| 2010 Q3 | 182.05 Million USD | -0.18% |
| 2010 Q4 | 186.42 Million USD | 2.4% |
| 2010 FY | 738.9 Million USD | 2.17% |
| 2010 Q1 | 188.03 Million USD | 4.45% |
| 2009 Q4 | 180.02 Million USD | 0.66% |
| 2009 FY | 723.22 Million USD | -2.16% |
| 2009 Q3 | 178.84 Million USD | -3.4% |
| 2009 Q1 | 179.22 Million USD | 3.26% |
| 2009 Q2 | 185.13 Million USD | 3.3% |
| 2008 Q4 | 173.56 Million USD | -3.96% |
| 2008 Q2 | 200.86 Million USD | 9.17% |
| 2008 Q1 | 184 Million USD | 2.98% |
| 2008 FY | 739.16 Million USD | 8.62% |
| 2008 Q3 | 180.72 Million USD | -10.03% |
| 2007 Q4 | 178.66 Million USD | 7.82% |
| 2007 Q1 | 164.07 Million USD | 5.11% |
| 2007 FY | 680.53 Million USD | 12.86% |
| 2007 Q2 | 172.08 Million USD | 4.88% |
| 2007 Q3 | 165.7 Million USD | -3.71% |
| 2006 FY | 602.98 Million USD | 7.04% |
| 2006 Q4 | 156.1 Million USD | 5.11% |
| 2006 Q3 | 148.52 Million USD | -2.88% |
| 2006 Q2 | 152.92 Million USD | 5.15% |
| 2006 Q1 | 145.43 Million USD | 0.93% |
| 2005 Q2 | 146.37 Million USD | 5.65% |
| 2005 Q3 | 134.32 Million USD | -8.23% |
| 2005 Q4 | 144.09 Million USD | 7.27% |
| 2005 Q1 | 138.54 Million USD | -5.37% |
| 2005 FY | 563.34 Million USD | 3.51% |
| 2004 Q1 | 134.02 Million USD | 18.1% |
| 2004 Q4 | 146.4 Million USD | 13.65% |
| 2004 Q3 | 128.82 Million USD | -4.58% |
| 2004 Q2 | 135 Million USD | 0.73% |
| 2004 FY | 544.26 Million USD | 8.52% |
| 2003 Q1 | 128.06 Million USD | 1.52% |
| 2003 Q4 | 113.48 Million USD | -9.85% |
| 2003 Q3 | 125.88 Million USD | -6.11% |
| 2003 Q2 | 134.08 Million USD | 4.7% |
| 2003 FY | 501.51 Million USD | 4.67% |
| 2002 FY | 479.13 Million USD | 22.44% |
| 2002 Q3 | 118.17 Million USD | -1.6% |
| 2002 Q4 | 126.14 Million USD | 6.74% |
| 2002 Q1 | 114.71 Million USD | -7.89% |
| 2002 Q2 | 120.09 Million USD | 4.69% |
| 2001 Q3 | 87.97 Million USD | -1.58% |
| 2001 Q4 | 124.54 Million USD | 41.57% |
| 2001 Q1 | 95.8 Million USD | 16.48% |
| 2001 Q2 | 89.39 Million USD | -6.69% |
| 2001 FY | 391.3 Million USD | 14.72% |
| 2000 Q4 | 82.25 Million USD | -2.87% |
| 2000 Q3 | 84.68 Million USD | -5.54% |
| 2000 Q2 | 89.65 Million USD | 6.08% |
| 2000 Q1 | 84.51 Million USD | 3.44% |
| 2000 FY | 341.09 Million USD | 5.93% |
| 1999 Q3 | 81.6 Million USD | 0.99% |
| 1999 FY | 322 Million USD | 3.01% |
| 1999 Q1 | 77.9 Million USD | -4.18% |
| 1999 Q2 | 80.8 Million USD | 3.72% |
| 1999 Q4 | 81.7 Million USD | 0.12% |
| 1998 Q3 | 80.7 Million USD | 3.86% |
| 1998 Q4 | 81.3 Million USD | 0.74% |
| 1998 FY | 312.6 Million USD | 16.34% |
| 1998 Q1 | 72.9 Million USD | 6.58% |
| 1998 Q2 | 77.7 Million USD | 6.58% |
| 1997 Q2 | 66.4 Million USD | -2.21% |
| 1997 FY | 268.7 Million USD | 15.17% |
| 1997 Q4 | 68.4 Million USD | 3.64% |
| 1997 Q3 | 66 Million USD | -0.6% |
| 1997 Q1 | 67.9 Million USD | 9.34% |
| 1996 Q2 | 57.6 Million USD | 1.05% |
| 1996 FY | 233.3 Million USD | 15.72% |
| 1996 Q4 | 62.1 Million USD | 9.72% |
| 1996 Q3 | 56.6 Million USD | -1.74% |
| 1996 Q1 | 57 Million USD | 8.16% |
| 1995 FY | 201.6 Million USD | 11.81% |
| 1995 Q4 | 52.7 Million USD | 1.35% |
| 1995 Q3 | 52 Million USD | 7.0% |
| 1995 Q2 | 48.6 Million USD | 0.62% |
| 1995 Q1 | 48.3 Million USD | 6.15% |
| 1994 FY | 180.3 Million USD | -9.76% |
| 1994 Q1 | 46.6 Million USD | -8.45% |
| 1994 Q2 | 46.5 Million USD | -0.21% |
| 1994 Q3 | 46 Million USD | -1.08% |
| 1994 Q4 | 45.5 Million USD | -1.09% |
| 1993 FY | 199.8 Million USD | 914.21% |
| 1993 Q4 | 50.9 Million USD | 20.62% |
| 1993 Q3 | 42.2 Million USD | -34.78% |
| 1993 Q2 | 64.7 Million USD | 567.01% |
| 1993 Q1 | 9.7 Million USD | -10.19% |
| 1992 Q2 | 7.6 Million USD | 35.71% |
| 1992 FY | 19.7 Million USD | 52.71% |
| 1992 Q3 | 9.8 Million USD | 28.95% |
| 1992 Q4 | 10.8 Million USD | 10.2% |
| 1992 Q1 | 5.6 Million USD | 7.69% |
| 1991 Q2 | 4.3 Million USD | 2.38% |
| 1991 Q3 | 4.5 Million USD | 4.65% |
| 1991 FY | 12.9 Million USD | 92.54% |
| 1991 Q1 | 4.2 Million USD | 0.0% |
| 1991 Q4 | 5.2 Million USD | 15.56% |
| 1990 Q4 | 4.2 Million USD | 61.54% |
| 1990 FY | 6.7 Million USD | 52.27% |
| 1990 Q3 | 2.6 Million USD | 44.44% |
| 1990 Q2 | 1.8 Million USD | 12.5% |
| 1990 Q1 | 1.6 Million USD | -5.88% |
| 1989 Q4 | 1.7 Million USD | 6.25% |
| 1989 Q1 | -15.9 Million USD | 0.0% |
| 1989 Q3 | 1.6 Million USD | -11.11% |
| 1989 Q2 | 1.8 Million USD | 111.32% |
| 1989 FY | 4.4 Million USD | 12.82% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -1620.533% |
| AngioDynamics, Inc. | 252.41 Million USD | -610.731% |
| AtriCure, Inc. | 327.05 Million USD | -448.535% |
| Avinger, Inc. | 18.63 Million USD | -9525.496% |
| Azenta, Inc. | 336.26 Million USD | -433.506% |
| BioLife Solutions, Inc. | 117.57 Million USD | -1425.809% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 1.688% |
| Daxor Corporation | 1.28 Million USD | -139999.882% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -7315.981% |
| Femasys Inc. | 15.2 Million USD | -11702.386% |
| GlucoTrack, Inc. | 7.1 Million USD | -25153.378% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -2962.426% |
| Hologic, Inc. | 1.34 Billion USD | -33.363% |
| ICU Medical, Inc. | 717.04 Million USD | -150.192% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 39.447% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -6771.491% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -1885.897% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1503506.548% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1503506.548% |
| Masimo Corporation | 867 Million USD | -106.92% |
| Microbot Medical Inc. | 9.85 Million USD | -18103.957% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -9639.38% |
| Merit Medical Systems, Inc. | 459.92 Million USD | -290.061% |
| Nephros, Inc. | 9.78 Million USD | -18236.059% |
| NovoCure Limited | 613.92 Million USD | -192.217% |
| NEXGEL, Inc. | 4.09 Million USD | -43698.828% |
| NEXGEL, Inc. | 4.09 Million USD | -43698.828% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -1654.643% |
| OraSure Technologies, Inc. | 125.34 Million USD | -1331.284% |
| Pro-Dex, Inc. | 7.37 Million USD | -24215.533% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -4017.134% |
| Predictive Oncology Inc. | 15.22 Million USD | -11679.746% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -20951.125% |
| QuidelOrtho Corporation | 1.35 Billion USD | -32.369% |
| Repligen Corporation | 261.12 Million USD | -587.033% |
| Sanara MedTech Inc. | 61.12 Million USD | -2834.865% |
| STAAR Surgical Company | 224.55 Million USD | -698.917% |
| Sharps Technology, Inc. | 10.12 Million USD | -17615.632% |
| Utah Medical Products, Inc. | 13.26 Million USD | -13428.392% |
| Jin Medical International Ltd. | 3.91 Million USD | -45693.67% |